14 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EUROIMMUN ANTI-M2-3E ELISA (IGG)

FDA 510(k)
FDA Class 2 ·Immunology

NEOCIF INSERTION INSTRUMENT

FDA Adverse Event
Malfunction ·BIOMET SPAIN, S.L.·Product code MQP·November 6, 2018

MONOJECT SAFETY NEEDLE

FDA 510(k)
FDA Class 2 ·General Hospital

HEART 2006

FDA 510(k)
FDA Class 2 ·Cardiovascular

NEOCIF INSERTION INSTRUMENT

FDA Adverse Event
Malfunction ·BIOMET SPAIN, S.L.·Product code MQP·July 20, 2017

MAGELLAN

FDA Adverse Event
Malfunction ·CARDINAL HEALTH, INC.·Product code FMI·September 6, 2023

RADIFOCUS OPTITORQUE

FDA Adverse Event
Malfunction ·TERUMO CORPORATION, ASHITAKA·Product code DQX·June 13, 2022

Kit BD Max GC RT PCR Assay; Catalog # 443486

FDA Enforcement
Class II ·Terminated·Becton Dickinson & Co.·August 28, 2019

ACTIVA

FDA Adverse Event
Malfunction ·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code MHY·May 3, 2013

HS III PROXIMAL SEAL SYTEM 3.8MM

FDA Adverse Event
Malfunction ·MAQUET CARDIOVASCULAR, LLC·Product code DXC·August 20, 2014

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·May 5, 2011

Exactech Equinoxe REVERSE SHOULDER, 38mm Humeral Liner: a) +0mm, Item Number 320-38-00, b) +2.5mm, Item Number 320-38-03; Shoulder Arthroplasty

FDA Enforcement
Class II ·Ongoing·Exactech, Inc.·April 10, 2024

Alaris Syringe Pump, Model No. 8110. Delivers fluids. Expansion of Affected Units: BOM Housing Assembly Service, Part No. 49000226, and Lower Housing/Carriage Block Assembly, Part No. 148188-100.

FDA Enforcement
Class I ·Terminated·CareFusion 303, Inc.·August 26, 2015

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024